Loading...
Header Logo
Keywords
Last Name
Institution

Jonathan Kay

Concepts (403)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
32
2018
192
8.010
Why?
Nephrogenic Fibrosing Dermopathy
16
2016
20
5.660
Why?
Antirheumatic Agents
23
2017
108
5.370
Why?
Contrast Media
16
2016
234
4.560
Why?
Gadolinium
14
2016
53
4.270
Why?
Rheumatic Diseases
9
2017
20
3.000
Why?
Methotrexate
10
2013
50
2.120
Why?
Antibodies, Monoclonal
13
2015
646
2.030
Why?
Kidney Failure, Chronic
12
2010
111
1.920
Why?
Rheumatology
7
2017
28
1.860
Why?
Spondylitis, Ankylosing
5
2016
14
1.340
Why?
Humans
92
2018
33646
1.320
Why?
Skin Diseases
5
2009
48
1.280
Why?
Skin
9
2012
229
1.270
Why?
Drug Approval
4
2013
13
1.260
Why?
Gadolinium DTPA
4
2016
48
1.250
Why?
Fibrosis
8
2013
59
1.180
Why?
Severity of Illness Index
15
2017
857
1.040
Why?
Middle Aged
35
2018
9785
0.890
Why?
Magnetic Resonance Imaging
7
2013
1007
0.890
Why?
Male
41
2018
17017
0.830
Why?
Kidney Diseases
3
2011
103
0.820
Why?
Scleroderma, Systemic
2
2008
6
0.790
Why?
Amyloidosis
9
2008
24
0.790
Why?
Renal Insufficiency, Chronic
4
2014
35
0.780
Why?
Tumor Necrosis Factor-alpha
10
2017
469
0.760
Why?
Female
42
2018
18827
0.740
Why?
Organometallic Compounds
3
2016
60
0.720
Why?
Aged
26
2018
7616
0.700
Why?
Therapeutic Equivalency
2
2016
4
0.680
Why?
Immunologic Factors
4
2015
48
0.680
Why?
Vasculitis
3
2013
38
0.680
Why?
Acute-Phase Proteins
2
2014
30
0.660
Why?
Macrophages
4
2014
711
0.660
Why?
Joints
2
2012
20
0.650
Why?
Adult
26
2018
9696
0.620
Why?
Risk Factors
11
2018
3017
0.620
Why?
C-Reactive Protein
4
2014
147
0.620
Why?
Biological Therapy
2
2012
10
0.610
Why?
beta 2-Microglobulin
10
2001
51
0.610
Why?
Arthritis, Psoriatic
2
2013
12
0.610
Why?
Meglumine
2
2016
9
0.600
Why?
Immunoglobulin G
4
2018
317
0.600
Why?
Peritonitis
1
2014
21
0.590
Why?
Peritoneum
1
2014
26
0.590
Why?
Treatment Outcome
13
2017
2593
0.590
Why?
Hypophosphatemia
1
2014
2
0.590
Why?
Blood Sedimentation
1
2014
8
0.580
Why?
Cryoglobulinemia
2
2005
7
0.580
Why?
Gastrointestinal Diseases
2
2013
59
0.550
Why?
Spondylarthropathies
1
2013
3
0.550
Why?
Polychondritis, Relapsing
1
2013
3
0.550
Why?
Infection
1
2013
58
0.550
Why?
Double-Blind Method
9
2016
472
0.550
Why?
Rare Diseases
1
2013
18
0.540
Why?
Myelodysplastic Syndromes
1
2013
43
0.530
Why?
Interleukin-1beta
1
2014
180
0.530
Why?
Biological Products
1
2012
20
0.520
Why?
Practice Guidelines as Topic
4
2014
433
0.510
Why?
Renal Insufficiency
2
2009
41
0.500
Why?
Kidney
4
2016
261
0.500
Why?
Pyrimidines
2
2011
75
0.500
Why?
Protein Kinase Inhibitors
2
2011
82
0.490
Why?
Osteoarthritis
2
2003
30
0.480
Why?
Piperazines
2
2011
93
0.480
Why?
Drugs, Generic
1
2011
9
0.480
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2012
148
0.470
Why?
Neoplasms
2
2013
586
0.460
Why?
Bursitis
1
2010
10
0.460
Why?
Renal Dialysis
6
2000
141
0.450
Why?
Software
2
2009
242
0.440
Why?
Autopsy
1
2009
25
0.430
Why?
Diabetes Complications
1
2010
90
0.430
Why?
Carrier Proteins
1
2014
588
0.420
Why?
Comorbidity
4
2013
721
0.410
Why?
Terminology as Topic
6
2016
97
0.400
Why?
Diagnosis, Differential
7
2016
637
0.400
Why?
Medical Records Systems, Computerized
1
2009
64
0.400
Why?
Cardiovascular Diseases
1
2013
511
0.390
Why?
Pulmonary Fibrosis
1
2008
20
0.380
Why?
Disease Progression
4
2016
472
0.360
Why?
Attitude of Health Personnel
2
2009
371
0.340
Why?
Receptors, Immunologic
5
2003
152
0.340
Why?
Temporal Arteries
1
2006
2
0.330
Why?
Giant Cell Arteritis
1
2006
2
0.330
Why?
Outcome Assessment (Health Care)
4
2015
386
0.330
Why?
Glomerulonephritis, Membranoproliferative
1
2005
2
0.330
Why?
Prevalence
4
2013
810
0.330
Why?
Antibodies, Antinuclear
2
2018
22
0.320
Why?
Dose-Response Relationship, Drug
8
2013
650
0.320
Why?
Biomedical Research
2
2017
141
0.310
Why?
Monocytes
4
2001
282
0.310
Why?
Interleukin-1
3
2004
136
0.300
Why?
Internationality
2
2015
28
0.300
Why?
Databases, Factual
3
2015
413
0.300
Why?
Glycosylation End Products, Advanced
1
2003
4
0.270
Why?
Gout
2
2016
38
0.260
Why?
Europe
5
2015
115
0.250
Why?
Lymphoproliferative Disorders
1
2002
31
0.250
Why?
Drug Industry
2
2012
30
0.250
Why?
Hepatitis C
1
2002
91
0.230
Why?
Hyperpigmentation
2
2012
2
0.230
Why?
Aged, 80 and over
6
2011
2893
0.230
Why?
Lyme Disease
2
1993
57
0.220
Why?
Remission Induction
4
2016
90
0.220
Why?
Fatal Outcome
3
2009
86
0.220
Why?
Synovial Fluid
2
1991
24
0.220
Why?
Iatrogenic Disease
1
2000
32
0.220
Why?
Animals
10
2016
14077
0.220
Why?
Biopsy
4
2011
260
0.220
Why?
Benzamides
2
2011
44
0.220
Why?
Disability Evaluation
2
2012
149
0.220
Why?
Drug Therapy, Combination
4
2013
314
0.210
Why?
Glucocorticoids
2
2013
95
0.200
Why?
Societies, Medical
4
2012
142
0.200
Why?
Case-Control Studies
3
2018
652
0.200
Why?
United States
3
2012
4037
0.190
Why?
Lymphoma
1
2018
69
0.180
Why?
Teriparatide
1
2017
3
0.180
Why?
Bone Diseases, Metabolic
1
2017
20
0.180
Why?
Cohort Studies
2
2013
1432
0.180
Why?
Bone Density Conservation Agents
1
2017
46
0.180
Why?
Review Literature as Topic
2
2016
31
0.180
Why?
Reproducibility of Results
3
2016
992
0.170
Why?
Retrospective Studies
4
2015
2623
0.170
Why?
Bone Density
1
2017
129
0.170
Why?
Drug Design
1
2017
87
0.170
Why?
Uric Acid
1
2016
40
0.170
Why?
Hand Bones
1
2016
1
0.170
Why?
Hand Joints
1
2016
1
0.170
Why?
Spondylarthritis
1
2016
3
0.170
Why?
Predictive Value of Tests
2
2009
675
0.170
Why?
Radiography
2
2016
282
0.170
Why?
Heterocyclic Compounds
1
2016
8
0.160
Why?
Area Under Curve
1
2016
74
0.160
Why?
Biological Availability
1
2016
88
0.160
Why?
International Agencies
1
2015
2
0.160
Why?
Advisory Committees
1
2015
27
0.150
Why?
Creatinine
3
2011
84
0.150
Why?
Drug Monitoring
1
2015
90
0.150
Why?
Fibronectins
2
1991
31
0.150
Why?
Inflammation Mediators
2
2013
116
0.140
Why?
Health Services Accessibility
1
2017
297
0.140
Why?
Apoptosis Regulatory Proteins
1
2014
114
0.140
Why?
Dexamethasone
1
1994
85
0.140
Why?
Caveolin 1
1
2013
5
0.140
Why?
Ear Cartilage
1
2013
8
0.140
Why?
Arthritis
1
2013
35
0.140
Why?
Guideline Adherence
2
2014
213
0.140
Why?
Cross-Sectional Studies
2
2015
1217
0.140
Why?
Hydrocortisone
1
1994
114
0.140
Why?
Scleroderma, Diffuse
1
2012
1
0.130
Why?
Transforming Growth Factor beta1
1
2013
39
0.130
Why?
Raynaud Disease
1
2012
4
0.130
Why?
Quality Assurance, Health Care
1
2015
214
0.130
Why?
Canada
1
2012
68
0.130
Why?
Osteoporosis
1
2013
110
0.130
Why?
Adolescent
4
2016
4046
0.130
Why?
Contracture
1
2012
6
0.130
Why?
Quality Indicators, Health Care
1
2015
246
0.130
Why?
Lung Diseases
1
2013
111
0.130
Why?
Hemoglobins
1
2013
104
0.130
Why?
Immunosuppressive Agents
1
2013
197
0.120
Why?
Shoulder
2
2010
13
0.120
Why?
North America
4
2015
82
0.120
Why?
Arthrography
1
2011
2
0.120
Why?
Opsonin Proteins
1
1991
29
0.120
Why?
Registries
1
2014
459
0.120
Why?
Ultrasonography
1
1992
292
0.120
Why?
Disease Models, Animal
2
2014
1149
0.120
Why?
Health Care Surveys
2
2009
234
0.120
Why?
Pilot Projects
1
2013
498
0.120
Why?
Dermis
1
2011
12
0.120
Why?
Hearing Loss, Sensorineural
1
2011
22
0.120
Why?
China
1
2011
64
0.120
Why?
Polymorphism, Single Nucleotide
1
2013
303
0.120
Why?
Shoulder Impingement Syndrome
1
2010
3
0.120
Why?
Muscular Diseases
2
2006
31
0.110
Why?
Range of Motion, Articular
1
2010
55
0.110
Why?
International Cooperation
4
2010
56
0.110
Why?
Pain Measurement
1
2011
202
0.110
Why?
Risk Reduction Behavior
1
2011
101
0.110
Why?
Recovery of Function
1
2011
143
0.110
Why?
Bone Resorption
1
2010
29
0.110
Why?
Mice, Knockout
1
2014
1522
0.110
Why?
Antineoplastic Agents
1
2013
333
0.110
Why?
Edema
2
2009
32
0.110
Why?
Bone and Bones
1
2010
97
0.110
Why?
Thromboembolism
1
2009
41
0.100
Why?
Serum Amyloid A Protein
1
2009
5
0.100
Why?
Clinical Trials as Topic
1
2011
295
0.100
Why?
E-Selectin
1
2009
21
0.100
Why?
Matrix Metalloproteinase 9
1
2009
39
0.100
Why?
Cause of Death
1
2009
115
0.100
Why?
Patient Satisfaction
1
2011
271
0.100
Why?
Medical Informatics Applications
1
2009
17
0.100
Why?
Interleukin-18
1
2009
55
0.100
Why?
Health Status
1
2011
314
0.100
Why?
Mice, Inbred C57BL
1
2014
2190
0.100
Why?
Eosinophilia
1
1988
23
0.100
Why?
Drug Eruptions
1
2008
12
0.100
Why?
Massachusetts
2
2011
1450
0.100
Why?
Risk Assessment
2
2011
1064
0.100
Why?
Chondrocalcinosis
1
2008
1
0.100
Why?
Uremia
1
2008
7
0.100
Why?
Pain
2
2006
214
0.100
Why?
Diabetes Mellitus, Type 2
2
2011
424
0.100
Why?
Mental Disorders
1
2013
466
0.100
Why?
Proportional Hazards Models
1
2009
454
0.100
Why?
Insulin Resistance
1
2011
298
0.100
Why?
Peripheral Nervous System Diseases
1
2008
12
0.100
Why?
Receptors, Cell Surface
1
1991
421
0.100
Why?
Quality of Life
1
2011
419
0.100
Why?
Pneumonia
1
2009
158
0.090
Why?
Drug Resistance
1
2008
59
0.090
Why?
Knee Joint
1
2008
61
0.090
Why?
Joint Diseases
1
2008
19
0.090
Why?
Shock, Septic
1
2008
50
0.090
Why?
Syndrome
1
2007
119
0.090
Why?
Health Knowledge, Attitudes, Practice
2
2009
581
0.090
Why?
Acanthamoeba
1
2006
1
0.090
Why?
Amebiasis
1
2006
2
0.090
Why?
Follow-Up Studies
2
2009
1514
0.090
Why?
Encephalitis
1
2006
22
0.090
Why?
Injections, Subcutaneous
3
2013
56
0.090
Why?
Granuloma
1
2006
30
0.090
Why?
Synovitis
3
2010
14
0.090
Why?
Acute-Phase Reaction
3
2010
13
0.090
Why?
Early Diagnosis
3
2010
45
0.080
Why?
Myocardium
1
2008
201
0.080
Why?
Lupus Erythematosus, Systemic
1
2006
73
0.080
Why?
Autoantibodies
2
2018
109
0.080
Why?
Pharyngitis
1
2006
11
0.080
Why?
Rocky Mountain Spotted Fever
1
2005
1
0.080
Why?
Exanthema
1
2005
13
0.080
Why?
Dyspnea
1
2006
43
0.080
Why?
Fatigue
1
2006
56
0.080
Why?
Prednisone
1
2005
58
0.080
Why?
Time Factors
6
2010
2562
0.080
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
144
0.070
Why?
Research Design
2
2017
377
0.070
Why?
Receptors, Interleukin-1
1
2004
61
0.070
Why?
Rabbits
1
2004
298
0.070
Why?
Anorexia Nervosa
1
1983
10
0.070
Why?
Models, Animal
1
2004
167
0.070
Why?
Mice
2
2014
7044
0.070
Why?
Collagen
3
1998
112
0.070
Why?
Tomography, X-Ray Computed
3
2017
862
0.060
Why?
Glucans
2
1994
27
0.060
Why?
Epidemiologic Methods
2
2014
68
0.060
Why?
Chromosomes, Human, Pair 3
1
2002
8
0.060
Why?
Trisomy
1
2002
8
0.060
Why?
Hypertension
1
2005
365
0.060
Why?
Phagocytosis
2
1994
191
0.060
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
92
0.060
Why?
Chronic Disease
2
2016
529
0.060
Why?
Receptors, Tumor Necrosis Factor
2
2013
53
0.060
Why?
Brain
1
2006
844
0.060
Why?
Randomized Controlled Trials as Topic
2
2013
335
0.050
Why?
Evidence-Based Medicine
2
2010
280
0.050
Why?
Aging
1
2003
512
0.050
Why?
Denmark
1
2018
9
0.050
Why?
Sweden
1
2018
21
0.050
Why?
Guanidines
1
1998
13
0.050
Why?
Lymphoma, Follicular
1
2018
15
0.050
Why?
Lymphoma, Non-Hodgkin
1
2018
30
0.050
Why?
Immunoglobulin M
1
2018
99
0.050
Why?
Immunoglobulin A
1
2018
43
0.050
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2018
33
0.050
Why?
Metacarpophalangeal Joint
1
2017
2
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
1
2018
39
0.050
Why?
Ulna
1
2017
4
0.050
Why?
Radius
1
2017
6
0.050
Why?
Hodgkin Disease
1
2018
46
0.050
Why?
Anti-Bacterial Agents
2
1993
375
0.040
Why?
Fibroblasts
1
1998
272
0.040
Why?
Health Priorities
1
2016
13
0.040
Why?
Carpal Tunnel Syndrome
1
1996
22
0.040
Why?
Algorithms
2
2010
638
0.040
Why?
Evaluation Studies as Topic
1
1996
104
0.040
Why?
Patient Care Planning
1
2016
50
0.040
Why?
Cells, Cultured
3
2001
1711
0.040
Why?
Enzyme Inhibitors
1
1998
269
0.040
Why?
ROC Curve
1
1996
150
0.040
Why?
Odds Ratio
1
2018
630
0.040
Why?
Apoptosis
1
2001
839
0.040
Why?
Patient Participation
1
2016
82
0.040
Why?
Guidelines as Topic
1
2016
117
0.040
Why?
Needs Assessment
1
2016
108
0.040
Why?
Asia
1
2015
11
0.040
Why?
Activities of Daily Living
1
1996
198
0.040
Why?
Logistic Models
1
2018
906
0.040
Why?
Immunohistochemistry
2
1998
735
0.040
Why?
Medication Adherence
1
2016
155
0.040
Why?
Life Style
1
2016
262
0.040
Why?
Electrophoresis, Gel, Two-Dimensional
2
1991
30
0.040
Why?
Receptors, Interleukin-6
1
2014
8
0.040
Why?
Feasibility Studies
1
2015
256
0.040
Why?
Sensitivity and Specificity
1
1996
782
0.040
Why?
Blood Proteins
1
1994
48
0.040
Why?
Image Processing, Computer-Assisted
1
2016
430
0.030
Why?
Codon
1
2013
30
0.030
Why?
Analysis of Variance
2
2009
535
0.030
Why?
Patient Education as Topic
1
2016
387
0.030
Why?
Gene Frequency
1
2013
98
0.030
Why?
Drug Administration Schedule
1
2013
215
0.030
Why?
Introns
1
2013
81
0.030
Why?
Anemia
1
2013
59
0.030
Why?
Bacterial Vaccines
1
1993
40
0.030
Why?
Shoulder Joint
1
1992
21
0.030
Why?
Bone Diseases
1
1992
18
0.030
Why?
Chi-Square Distribution
1
2013
356
0.030
Why?
Kinetics
1
1994
654
0.030
Why?
Cell Line
2
1998
1669
0.030
Why?
Precipitin Tests
1
1991
84
0.030
Why?
Chromatography, Affinity
1
1991
42
0.030
Why?
Molecular Weight
1
1991
170
0.030
Why?
Multivariate Analysis
1
2013
708
0.030
Why?
Cell Count
1
2011
115
0.030
Why?
Clinical Chemistry Tests
1
2010
3
0.030
Why?
Decision Making, Computer-Assisted
1
2010
10
0.030
Why?
Cytokines
1
2014
681
0.030
Why?
Phenotype
1
2013
770
0.030
Why?
Genetic Predisposition to Disease
1
2013
437
0.030
Why?
Consensus
1
2010
47
0.030
Why?
Epitopes
1
1991
229
0.030
Why?
Osteoclasts
1
2010
38
0.030
Why?
Receptors, Cytoadhesin
1
1989
1
0.030
Why?
Receptors, Very Late Antigen
1
1989
1
0.030
Why?
Blotting, Western
1
1991
525
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
1989
103
0.030
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2009
7
0.030
Why?
Leg
1
2009
71
0.030
Why?
Decision Support Techniques
1
2010
92
0.030
Why?
Drug Synergism
1
2009
99
0.030
Why?
Antibodies
2
2001
142
0.030
Why?
Osteoblasts
1
2010
151
0.030
Why?
Incidence
1
2011
814
0.020
Why?
Safety
1
2009
118
0.020
Why?
Patient Selection
1
2010
282
0.020
Why?
Borrelia
1
1988
21
0.020
Why?
Calcium Oxalate
1
2008
9
0.020
Why?
Bone Remodeling
1
2008
22
0.020
Why?
Pregnancy
1
1993
1238
0.020
Why?
Receptors, Antigen, T-Cell
1
1989
205
0.020
Why?
Crystallization
1
2008
79
0.020
Why?
Prospective Studies
1
2012
1650
0.020
Why?
Fluorescent Antibody Technique
1
1988
206
0.020
Why?
Antibodies, Bacterial
1
1988
126
0.020
Why?
Glycosylation
2
1998
87
0.020
Why?
Blood Chemical Analysis
1
2006
16
0.020
Why?
Lymphocyte Activation
1
1989
652
0.020
Why?
Muscle Weakness
1
2006
18
0.020
Why?
Arm
1
2006
37
0.020
Why?
Controlled Clinical Trials as Topic
1
2006
6
0.020
Why?
Seizures
1
2006
50
0.020
Why?
Child
1
1993
2691
0.020
Why?
CD4-Positive T-Lymphocytes
1
1989
502
0.020
Why?
Eosinophilia-Myalgia Syndrome
1
2004
1
0.020
Why?
Young Adult
1
2011
2215
0.020
Why?
Acanthocytes
1
1983
1
0.020
Why?
Bone Marrow Examination
1
1983
9
0.020
Why?
Leukopenia
1
1983
13
0.020
Why?
Leukocyte Count
1
1983
82
0.020
Why?
Dietary Proteins
1
1983
32
0.020
Why?
Disease Susceptibility
1
1983
99
0.020
Why?
Complement System Proteins
1
1983
74
0.020
Why?
Dietary Carbohydrates
1
1983
70
0.020
Why?
Staphylococcal Infections
1
1983
70
0.020
Why?
Attitude to Health
1
1983
257
0.010
Why?
Dinoprostone
1
2001
45
0.010
Why?
Superoxides
1
2001
77
0.010
Why?
Fas Ligand Protein
1
2001
31
0.010
Why?
Intracellular Membranes
1
2001
43
0.010
Why?
Stress, Psychological
1
1983
270
0.010
Why?
Lysosomes
1
2001
112
0.010
Why?
Antigens, Surface
1
2001
174
0.010
Why?
Propionibacterium acnes
1
1979
6
0.010
Why?
Immunosuppression
1
1979
79
0.010
Why?
Procollagen
1
1998
5
0.010
Why?
Cytotoxicity, Immunologic
1
1979
129
0.010
Why?
Gastric Mucosa
1
1998
37
0.010
Why?
Epidermal Growth Factor
1
1998
49
0.010
Why?
Spectrometry, Fluorescence
1
1998
80
0.010
Why?
Membrane Glycoproteins
1
2001
582
0.010
Why?
Immunoblotting
1
1998
180
0.010
Why?
Intestinal Mucosa
1
1998
147
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1998
399
0.010
Why?
Glucose
1
1998
311
0.010
Why?
T-Lymphocytes
1
1979
829
0.010
Why?
RNA, Messenger
1
1998
1209
0.010
Why?
Hip
1
1992
8
0.010
Why?
Wrist
1
1992
15
0.010
Why?
Spine
1
1992
32
0.010
Why?
Antigens, Differentiation
1
1989
118
0.010
Why?
Extracellular Matrix
1
1989
92
0.010
Why?
Ascitic Fluid
1
1979
12
0.000
Why?
Leukemia, Experimental
1
1979
16
0.000
Why?
Mice, Inbred CBA
1
1979
88
0.000
Why?
Cell Separation
1
1979
133
0.000
Why?
Cell Adhesion
1
1979
196
0.000
Why?
Immunity, Cellular
1
1979
158
0.000
Why?
Spleen
1
1979
435
0.000
Why?
Kay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_